Study of OTO-104 in Subjects With Unilateral Meniere's Disease

PHASE3TerminatedINTERVENTIONAL

Enrollment

176

Participants

Timeline

Start Date

March 21, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

September 15, 2017

Conditions

Meniere's Disease

Interventions

DRUG

OTO-104

Single intratympanic injection of 12 mg OTO-104

DRUG

Placebo

Single intratympanic injection of placebo

Trial Locations (1)

Many sites in Europe. Refer to the contact info listed below., San Diego